Editing Management of Localized Prostate Cancer (section)

==== <span style="color:#ff0000">Advantages of AS</span> ====
# '''<span style="color:#ff0000">Reduce overdiagnosis/overtreatment of prostate cancer</span>'''
#* '''Overdiagnosis refers to a cancer detected by screening that would not be detected during the patient’s lifetime without screening or would never cause disability or death.'''
#** There is substantial overdiagnosis of prostate cancer as a result of widespread PSA screening coupled with aggressive biopsy regimens.
#** Any screening program will involve detection of some cancers that would not have been otherwise detected.
#* '''Overtreatment refers to treatment of men who would otherwise not have known about their cancer in the absence of PSA testing.'''
#** The risk of overtreatment of prostate cancer is high when prostate cancer is discovered on prostate biopsies triggered by PSA testing—the most common scenario.
'''<span style="color:#ff0000">Disadvantages of AS</span>'''
# '''<span style="color:#ff0000">Risk of multiple biopsy procedures</span>'''
#* '''Risks of repeat biopsies include infections, erectile dysfunction, complicate subsequent attempts at nerve-sparing surgery'''
# '''<span style="color:#ff0000">Delaying treatment and possibly missing the window of opportunity for cure</span>'''